Company Quick10K Filing
Oncolix
10-Q 2018-09-30 Filed 2018-11-19
10-Q 2018-06-30 Filed 2018-08-09
10-Q 2018-03-31 Filed 2018-05-14
S-1 2018-03-21 Public Filing
10-K 2017-12-31 Filed 2018-03-14
10-Q 2017-09-30 Filed 2017-10-23
10-Q 2017-06-30 Filed 2017-08-18
10-Q 2017-03-31 Filed 2017-05-15
10-K 2016-12-31 Filed 2017-04-05
10-Q 2016-09-30 Filed 2016-11-22
10-Q 2016-06-30 Filed 2016-08-12
10-Q 2016-03-31 Filed 2016-05-16
10-K 2015-12-31 Filed 2016-04-14
10-Q 2015-09-30 Filed 2015-11-16
10-Q 2015-06-30 Filed 2015-08-19
10-Q 2015-03-31 Filed 2015-05-20
10-K 2014-12-31 Filed 2015-03-26
8-K 2019-07-02 Other Events
8-K 2019-03-06 Other Events
8-K 2019-02-18 Enter Agreement, Shareholder Rights, Amend Bylaw, Exhibits
8-K 2019-01-23 Sale of Shares, Other Events
8-K 2018-11-29 Enter Agreement, Off-BS Arrangement, Off-BS Arrangement, Other Events, Exhibits
8-K 2018-10-11 Regulation FD, Exhibits
8-K 2018-06-26 Officers
8-K 2018-06-25 Amend Bylaw, Shareholder Vote, Exhibits
8-K 2018-06-01 Enter Agreement, Off-BS Arrangement, Sale of Shares, Shareholder Rights, Exhibits
8-K 2018-04-27 Other Events

Oncolix Financials

ONCX Metrics, Comps, Filings

Quarterly | Annual

Business

Oncolix, Inc. was incorporated in the State of Florida in June 2013. During September 2017, the name of the corporation was changed from Advanced Environmental Petroleum Producers, Inc. ("AEPP") to Oncolix, Inc. in connection with the reorganization described in the following paragraph.

On April 8, 2017, Oncolix, Inc., a private Delaware corporation ("Oncolix/DE") acquired approximately 66% of the outstanding common stock of AEPP, a public Florida corporation traded on the OTC Pink with limited or no operating activities and no indebtedness. Oncolix/DE paid $315,000 in cash to a controlling shareholder of AEPP and also paid a fee to an investment banker of $50,000 in connection with this transaction. On August 3, 2017, AEPP Merger Sub, Inc., a wholly-owned subsidiary of AEPP ("Merger Sub"), merged with Oncolix/DE, and AEPP assumed responsibility for the issuance of equity securities in exchange for the equity securities of Oncolix/DE ("Merger"). On September 28, 2017, AEPP filed an amendment with the Florida Secretary of State and changed its name to Oncolix, Inc.

The Merger was treated as a reverse acquisition of AEPP (subsequently renamed Oncolix, Inc. as noted above) by Oncolix/DE for financial accounting and reporting purposes. As such, Oncolix/DE is treated as the acquirer for accounting and financial reporting purposes while AEPP is treated as the acquired entity for accounting and financial reporting purposes. Accordingly, the financial statements included in this Form 10-K for all periods prior to August 3, 2017 are those of Oncolix/DE. Because of the acquisition of a controlling interest on April 8, 2017, the financial statements of AEPP have been consolidated with Oncolix/DE since April 2017. AEPP's assets, liabilities and results of operations for periods after April 2017 are the consolidated assets, liabilities and results of operations of Oncolix, Inc. and its wholly owned subsidiary Oncolix/DE.


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
HST Global (HSTC) 1,274 2.8 2,050% 22 0 0 0 452 443 1,257
Spine Injury Solutions (SPIN) 1,214 24% -0.9 -75% 1,709 1,327 151 35 -1,279 -1,177 1,025
Sharing Economy International (SEII) 1,206 -93% -0.1 -198% 14,224 7,563 5,244 -4,862 -28,102 -27,274 1,857
Spectral Capital (FCCN) 1,179 0% -8.6 -21,809% 1 881 0 0 -137 -137 1,178
Argos Therapeutics (ARGS) 1,165 0% -1.3 -106% 10,881 23,454 8,905 0 -11,529 -8,973 11,710
Yulong Eco-Materials (YECO) 1,133 31% 0.0 -200% 33,278 29,559 10,084 3,137 -66,490 -64,932 -681
MicroChannel Technologies (MCTC) 29,418 -997.6 0 158 0 0 -29 -29 29,418
Capstone Therapeutics (CAPS) 1,088 -1.4 -315% 703 3,463 0 0 -2,216 -2,173 2,961
Franchise Holdings International (FNHI) 1,086 20% -9.2 -19% 848 1,267 1,448 293 -158 -103 950
Oncolix (ONCX) 1,085 -1.0 -2,427% 297 7,602 0 0 -7,200 -6,988 7,169
Q2Earth (QPWR) 1,040 0% 6.5 1,037% 15 4,036 3,142 0 159 159 1,037
ColorStars (CSTU) 1,023 100% -8.6 -119% 101 450 7 7 -121 -119 1,015
Arias Intel (ASNT) 1,014 -0.1 -1,260% 723 6,449 0 0 -9,111 -8,536 1,014
Altex Industries (ALTX) 984 0% -183.1 -1% 2,344 1,091 56 0 -32 7 -1,282
Propanc Biopharma (PPCB) 983 -1.0 -2,593% 198 4,739 0 -24 -5,125 -3,561 3,434
TX Holdings (TXHG) 961 16% 8.3 2% 2,141 4,095 3,935 621 42 174 1,438
Axion Power (AXPW) 960 -2,624% -0.1 -1,826% 578 8,143 58 -1,527 -10,558 -10,312 759
GeoVax Labs (GOVX) 956 0% -0.2 -218% 817 1,837 907 0 -1,780 -1,771 416
Virtual Crypto Technologies (VRCP) 922 98% -1.2 -271% 235 1,546 63 62 -638 -642 756
ZIM (ZIMCF) 895 -0% 0 0 0 0 388

Balance Sheet ($'000)2014-12-312015-03-312015-06-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-30
Cash1520000020931,36149430579123
Accounts Receivable
Inventory
PP&E0000
Assets17544440204601,677889404931297
Accounts Payable831031101281441601562260626262626262
Long-Term Debt8971,8895,7016,208
Liabilities31433935130432430528522603,4982,1342,5313,5467,2977,602
Stockholders' Equity-296-333-347-301-321-302-285-2240-3,038-457-1,642-3,141-6,366-7,305
Income Statement ($'000)2014-12-312015-03-312015-06-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-30
Revenue00000000000
Cost of Revenue
Gross Profit
R&D3000000777631010492211
SG&A711000042794350346296298222
Tax000000
Net Income-37-14-24-19-14-4,760-286-867-803-1,220-1,499-3,422-1,059
Cash Flow ($'000)2014-12-312015-03-312015-06-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-30
Cash Operating-10-2-16-4,748-2-951-601-827-464-400-455
Cash Investing4-7400
Cash Financing124,7501,869-3909490